Loading clinical trials...
Loading clinical trials...
Stereotactic Ablative Radiotherapy in Patients With Hypertrophic Obstructive Cardiomyopathy: First in Man Pilot Study
Conditions
Interventions
stereotactic ablative radiotherapy
Locations
1
China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Start Date
January 12, 2021
Primary Completion Date
April 30, 2022
Completion Date
November 1, 2022
Last Updated
November 30, 2022
NCT04349072
NCT04770142
NCT04141891
NCT04066777
NCT04905173
NCT04777188
Lead Sponsor
Second Xiangya Hospital of Central South University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions